NASDAQ:ASPI - Nasdaq - US00218A1051 - Common Stock - Currency: USD
4.77
-0.13 (-2.65%)
The current stock price of ASPI is 4.77 USD. In the past month the price decreased by -27.95%. In the past year, price increased by 25.53%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
SHW | SHERWIN-WILLIAMS CO/THE | 30.41 | 86.78B | ||
ECL | ECOLAB INC | 39.74 | 74.95B | ||
DD | DUPONT DE NEMOURS INC | 20.06 | 34.13B | ||
PPG | PPG INDUSTRIES INC | 14.17 | 26.63B | ||
IFF | INTL FLAVORS & FRAGRANCES | 18.58 | 20.43B | ||
RPM | RPM INTERNATIONAL INC | 22.82 | 15.58B | ||
EMN | EASTMAN CHEMICAL CO | 12.51 | 11.44B | ||
SQM | QUIMICA Y MINERA CHIL-SP ADR | N/A | 11.33B | ||
ALB | ALBEMARLE CORP | N/A | 9.54B | ||
AXTA | AXALTA COATING SYSTEMS LTD | 16.08 | 7.86B | ||
ESI | ELEMENT SOLUTIONS INC | 18.4 | 6.42B | ||
ALTM | ARCADIUM LITHIUM PLC | 12.65 | 6.26B |
ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. The company is headquartered in Washington, Washington Dc and currently employs 76 full-time employees. The company went IPO on 2022-11-10. The firm is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The firm employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
ASP ISOTOPES INC
1101 Pennsylvania Avenue Nw, Suite 300
WASHINGTON WASHINGTON DC US
Employees: 76
Company Website: https://aspisotopes.com/
Investor Relations: https://aspisotopes.com/corporate-governance/
Phone: 12027562245
The current stock price of ASPI is 4.77 USD. The price decreased by -2.65% in the last trading session.
The exchange symbol of ASP ISOTOPES INC is ASPI and it is listed on the Nasdaq exchange.
ASPI stock is listed on the Nasdaq exchange.
8 analysts have analysed ASPI and the average price target is 6.63 USD. This implies a price increase of 38.99% is expected in the next year compared to the current price of 4.77. Check the ASP ISOTOPES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ASP ISOTOPES INC (ASPI) has a market capitalization of 340.53M USD. This makes ASPI a Small Cap stock.
ASP ISOTOPES INC (ASPI) currently has 76 employees.
ASP ISOTOPES INC (ASPI) has a support level at 4.49 and a resistance level at 6.05. Check the full technical report for a detailed analysis of ASPI support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ASPI does not pay a dividend.
ASP ISOTOPES INC (ASPI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.61).
The outstanding short interest for ASP ISOTOPES INC (ASPI) is 31.41% of its float. Check the ownership tab for more information on the ASPI short interest.
ChartMill assigns a technical rating of 1 / 10 to ASPI. When comparing the yearly performance of all stocks, ASPI is a bad performer in the overall market: 75.77% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to ASPI. While ASPI seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months ASPI reported a non-GAAP Earnings per Share(EPS) of -0.61. The EPS decreased by -32.74% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -35.77% | ||
ROE | -77.77% | ||
Debt/Equity | 0.87 |
ChartMill assigns a Buy % Consensus number of 83% to ASPI. The Buy consensus is the average rating of analysts ratings from 8 analysts.